Cumulative survival in early-onset unilateral and bilateral breast cancer: An analysis of 1907 Taiwanese women

W. H. Kuo, A. M F Yen, P. H. Lee, K. M. Chen, J. Wang, K. J. Chang, T. H H Chen, H. S. Tsau

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

As the epidemiological pattern of breast cancer in modernising Asian countries differs greatly from that in Western countries, it is worthwhile to investigate the long-term prognoses of unilateral and bilateral breast cancer in these nations. A retrospective cohort study composed of 1907 Taiwanese women was conducted to follow 1863 unilateral and 44 bilateral cases of breast cancer. Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development. The 15-year survival rates were 68.37, 62.63, and 26.42% for unilateral, synchronous bilateral, and metachronous bilateral breast cancer, respectively. Differences among types were most apparent after 5 years of follow-up. After adjusting for significant prognostic factors, the risk of death for overall bilateral breast cancer was 2.50-fold greater (95% CI, 1.43-4.37) compared to unilateral breast cancer. The corresponding figures were 1.12-fold (95% CI, 0.42-3.02) and 6.11-fold (95% CI, 3.14-11.89) for synchronous and metachronous bilateral breast cancer, respectively. Taiwanese women, who are frequently diagnosed with breast cancer before 50 years of age, showed poorer survival for metachronous bilateral than for synchronous bilateral or unilateral breast cancer. Survival was markedly poorer compared to recent data from Sweden.

Original languageEnglish
Pages (from-to)563-570
Number of pages8
JournalBritish Journal of Cancer
Volume100
Issue number4
DOIs
Publication statusPublished - Feb 24 2009
Externally publishedYes

Fingerprint

Breast Neoplasms
Survival
Unilateral Breast Neoplasms
Sweden
Cohort Studies
Survival Rate
Retrospective Studies
Neoplasms

Keywords

  • Bilateral breast cancer
  • Early-onset breast cancer
  • Metachronous breast cancer
  • Survival
  • Synchronous breast cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cumulative survival in early-onset unilateral and bilateral breast cancer : An analysis of 1907 Taiwanese women. / Kuo, W. H.; Yen, A. M F; Lee, P. H.; Chen, K. M.; Wang, J.; Chang, K. J.; Chen, T. H H; Tsau, H. S.

In: British Journal of Cancer, Vol. 100, No. 4, 24.02.2009, p. 563-570.

Research output: Contribution to journalArticle

Kuo, W. H. ; Yen, A. M F ; Lee, P. H. ; Chen, K. M. ; Wang, J. ; Chang, K. J. ; Chen, T. H H ; Tsau, H. S. / Cumulative survival in early-onset unilateral and bilateral breast cancer : An analysis of 1907 Taiwanese women. In: British Journal of Cancer. 2009 ; Vol. 100, No. 4. pp. 563-570.
@article{37d1a719af17468785d6451dd591f165,
title = "Cumulative survival in early-onset unilateral and bilateral breast cancer: An analysis of 1907 Taiwanese women",
abstract = "As the epidemiological pattern of breast cancer in modernising Asian countries differs greatly from that in Western countries, it is worthwhile to investigate the long-term prognoses of unilateral and bilateral breast cancer in these nations. A retrospective cohort study composed of 1907 Taiwanese women was conducted to follow 1863 unilateral and 44 bilateral cases of breast cancer. Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development. The 15-year survival rates were 68.37, 62.63, and 26.42{\%} for unilateral, synchronous bilateral, and metachronous bilateral breast cancer, respectively. Differences among types were most apparent after 5 years of follow-up. After adjusting for significant prognostic factors, the risk of death for overall bilateral breast cancer was 2.50-fold greater (95{\%} CI, 1.43-4.37) compared to unilateral breast cancer. The corresponding figures were 1.12-fold (95{\%} CI, 0.42-3.02) and 6.11-fold (95{\%} CI, 3.14-11.89) for synchronous and metachronous bilateral breast cancer, respectively. Taiwanese women, who are frequently diagnosed with breast cancer before 50 years of age, showed poorer survival for metachronous bilateral than for synchronous bilateral or unilateral breast cancer. Survival was markedly poorer compared to recent data from Sweden.",
keywords = "Bilateral breast cancer, Early-onset breast cancer, Metachronous breast cancer, Survival, Synchronous breast cancer",
author = "Kuo, {W. H.} and Yen, {A. M F} and Lee, {P. H.} and Chen, {K. M.} and J. Wang and Chang, {K. J.} and Chen, {T. H H} and Tsau, {H. S.}",
year = "2009",
month = "2",
day = "24",
doi = "10.1038/sj.bjc.6604898",
language = "English",
volume = "100",
pages = "563--570",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Cumulative survival in early-onset unilateral and bilateral breast cancer

T2 - An analysis of 1907 Taiwanese women

AU - Kuo, W. H.

AU - Yen, A. M F

AU - Lee, P. H.

AU - Chen, K. M.

AU - Wang, J.

AU - Chang, K. J.

AU - Chen, T. H H

AU - Tsau, H. S.

PY - 2009/2/24

Y1 - 2009/2/24

N2 - As the epidemiological pattern of breast cancer in modernising Asian countries differs greatly from that in Western countries, it is worthwhile to investigate the long-term prognoses of unilateral and bilateral breast cancer in these nations. A retrospective cohort study composed of 1907 Taiwanese women was conducted to follow 1863 unilateral and 44 bilateral cases of breast cancer. Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development. The 15-year survival rates were 68.37, 62.63, and 26.42% for unilateral, synchronous bilateral, and metachronous bilateral breast cancer, respectively. Differences among types were most apparent after 5 years of follow-up. After adjusting for significant prognostic factors, the risk of death for overall bilateral breast cancer was 2.50-fold greater (95% CI, 1.43-4.37) compared to unilateral breast cancer. The corresponding figures were 1.12-fold (95% CI, 0.42-3.02) and 6.11-fold (95% CI, 3.14-11.89) for synchronous and metachronous bilateral breast cancer, respectively. Taiwanese women, who are frequently diagnosed with breast cancer before 50 years of age, showed poorer survival for metachronous bilateral than for synchronous bilateral or unilateral breast cancer. Survival was markedly poorer compared to recent data from Sweden.

AB - As the epidemiological pattern of breast cancer in modernising Asian countries differs greatly from that in Western countries, it is worthwhile to investigate the long-term prognoses of unilateral and bilateral breast cancer in these nations. A retrospective cohort study composed of 1907 Taiwanese women was conducted to follow 1863 unilateral and 44 bilateral cases of breast cancer. Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development. The 15-year survival rates were 68.37, 62.63, and 26.42% for unilateral, synchronous bilateral, and metachronous bilateral breast cancer, respectively. Differences among types were most apparent after 5 years of follow-up. After adjusting for significant prognostic factors, the risk of death for overall bilateral breast cancer was 2.50-fold greater (95% CI, 1.43-4.37) compared to unilateral breast cancer. The corresponding figures were 1.12-fold (95% CI, 0.42-3.02) and 6.11-fold (95% CI, 3.14-11.89) for synchronous and metachronous bilateral breast cancer, respectively. Taiwanese women, who are frequently diagnosed with breast cancer before 50 years of age, showed poorer survival for metachronous bilateral than for synchronous bilateral or unilateral breast cancer. Survival was markedly poorer compared to recent data from Sweden.

KW - Bilateral breast cancer

KW - Early-onset breast cancer

KW - Metachronous breast cancer

KW - Survival

KW - Synchronous breast cancer

UR - http://www.scopus.com/inward/record.url?scp=60349091874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60349091874&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6604898

DO - 10.1038/sj.bjc.6604898

M3 - Article

C2 - 19190627

AN - SCOPUS:60349091874

VL - 100

SP - 563

EP - 570

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -